$2.89 0.03 (+1.05%)
12/4/2009 11:46 AM

ATS Medical, Inc. (ATSI)

CAPS Rating: 4 out of 5

The Company develops, manufactures and markets medical devices for use by cardiovascular or cardiothoracic surgeons during cardiac surgery.

Current Price $2.89 Mkt Cap $208.3M
Open $2.94 P/E Ratio 0.00
Prev. Close $2.86 Div. (Yield) N/A (N/A)
Daily Range $2.89 - $2.94 Volume 74,664
52-Wk Range $2.04 - $3.58 Avg. Daily Vol. 292,000

ATSI News and Commentary

Caps

How do you think ATSI will perform vs the S&P 500?

Add Stock to Watchlist

All Members

203 Outperform
4 Underperform
 

All-Star Members

34 Outperform
1 Underperform
 

Wall Street

6 Outperform
0 Underperform
 

Top ATSI Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

RiverRover (88.26)
Submitted April 23, 2009

Great company. Great fundamentals. Lots of growth potential long term. Provides heart valves, etc., for people all over the world. It's a Minnesota company (my home state) and in the top 100 companies of Minnesota, according to the Mpls Star Tribune.

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

ATSI VS S&P 500 (SPY)

Fools bullish on ATSI are also bullish on:

Recent Community Commentary

Read the most recent pitches from members about ATSI.

Recs

0
Member Avatar catfishalex (83.57) Submitted: 11/11/2009 7:44:57 PM : Underperform Start Price: $2.86 ATSI Score: -1.05

They must have one hell of a heart valve to get this kind of CAPS rating with a -3 PEG and a long history of negative EBITDA.

Recs

0
Member Avatar DasCapitolin (< 20) Submitted: 10/1/2009 11:12:27 AM : Outperform Start Price: $2.68 ATSI Score: +2.47

ATS Medical is just getting started. Good long-term growth and decent fundamentals point to long-term outperform. The medical market sector is volatile with pending healthcare reform laws, but either way this medical device manufacturer stands to gain from the high rate of cardiovascular disease.

Recs

0
Member Avatar drgroup (63.55) Submitted: 8/27/2009 9:12:43 AM : Underperform Start Price: $3.00 ATSI Score: +10.98

With the death panels in the obwana sorry excuse for a health plan, there will be no need for developing heart implant devices. ATS will be levereged to swing into the embalming and casket business to prop up their bottom line.

Leaderboard

Find the members with the highest scoring picks in ATSI.

Score Leader

jasocurt

jasocurt (94.31) Score: +117.17

The Score Leader is the member with the highest score across all their picks in ATSI.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score Commentary
McLovin 86.69 10/9/2007 Outperform 5Y $1.72 +69.77% -25.16% +94.93
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. deeann001 < 20 4/4/2008 Outperform 3Y $1.67 +74.85% -16.24% +91.09
cmain2009 79.62 2/28/2008 Outperform 1Y $1.67 +74.43% -15.43% +89.87
REM071682 < 20 2/28/2008 Outperform 3Y $1.69 +72.78% -15.59% +88.38 1 Comment
BigGainsHunter 65.14 9/26/2007 Outperform NS $1.79 +63.13% -23.44% +86.57
smallcapfool1 38.00 10/3/2007 Outperform 1Y $1.80 +62.22% -24.29% +86.51
onthewatch < 20 7/30/2007 Outperform NS $1.76 +65.91% -19.82% +85.73
ronanmac 57.35 7/30/2007 Outperform 1Y $1.76 +65.91% -19.82% +85.73
Andy1090 34.76 10/23/2007 Outperform 1Y $1.80 +62.22% -23.11% +85.34
pops83 47.87 4/4/2008 Outperform 3Y $1.73 +68.79% -16.35% +85.13 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackPiperJaff 80.86 11/4/2009 Outperform NS $2.94 -0.68% +7.14% -7.82
TrackJohnRogers < 20 9/23/2009 Outperform 1Y $2.82 +3.55% +3.57% -0.02 1 Comment
TrackZacks 72.27 3/19/2009 Outperform 3M $2.20 +44.09% +11.55% +32.54 7/7/2009 @ $3.17 1 Comment
TrackFeltlandCo 39.48 7/21/2008 Outperform NS $2.44 +19.77% -9.29% +29.06
TrackCanaccord 78.29 5/6/2008 Outperform NS $2.03 +43.84% -18.38% +62.22
TrackRodmanRen < 20 2/28/2008 Outperform NS $1.69 +72.78% -15.59% +88.38
TrackRBCCapMkts 83.29 2/1/2008 Outperform NS $1.65 +76.97% -16.02% +92.99

Featured Broker Partners